Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali
- 13 August 2004
- Vol. 22 (23-24) , 3169-3174
- https://doi.org/10.1016/j.vaccine.2004.01.054
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional studyBMJ, 2001
- Severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infantsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Is Fever a Good Sign for Clinical Malaria in Surveys of Endemic Communities?The American Journal of Tropical Medicine and Hygiene, 1995
- Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programmeThe Lancet, 1995
- A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and designVaccine, 1994
- Attributable fraction estimates and case definitions for malaria in endemicStatistics in Medicine, 1994
- Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of EcuadorVaccine, 1994
- The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityVaccine, 1992
- The effect of insecticide-treated bed nets on mortality of Gambian childrenThe Lancet, 1991